Citation: Dg. Demirov et al., The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner, J VIROLOGY, 76(1), 2002, pp. 105-117
Authors:
Tang, SX
Murakami, T
Agresta, BE
Campbell, S
Freed, EO
Levin, JG
Citation: Sx. Tang et al., Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibitaberrant core morphology and are blocked in initiation of reverse transcription in infected cells, J VIROLOGY, 75(19), 2001, pp. 9357-9366
Authors:
Banks, WA
Freed, EO
Wolf, KM
Robinson, SM
Franko, M
Kumar, VB
Citation: Wa. Banks et al., Transport of human immunodeficiency virus type 1 pseudoviruses across the blood-brain barrier: Role of envelope proteins and adsorptive endocytosis, J VIROLOGY, 75(10), 2001, pp. 4681-4691
Citation: T. Murakami et Eo. Freed, The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions, P NAS US, 97(1), 2000, pp. 343-348
Citation: T. Murakami et Eo. Freed, Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail, J VIROLOGY, 74(8), 2000, pp. 3548-3554
Citation: A. Ono et al., Role of the gag matrix domain in targeting human immunodeficiency virus type 1 assembly, J VIROLOGY, 74(6), 2000, pp. 2855-2866
Citation: A. Ono et al., Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding, J VIROLOGY, 74(11), 2000, pp. 5142-5150
Citation: Re. Kiernan et al., Reversion of a human immunodeficiency virus type 1 matrix mutation affecting Gag membrane binding, endogenous reverse transcriptase activity, and virus infectivity, J VIROLOGY, 73(6), 1999, pp. 4728-4737
Citation: A. Ono et Eo. Freed, Binding of human immunodeficiency virus type 1 Gag to membrane: Role of the matrix amino terminus, J VIROLOGY, 73(5), 1999, pp. 4136-4144